Literature DB >> 12149359

Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.

C García-Rey1, L Aguilar, F Baquero, J Casal, J E Martín.   

Abstract

The M phenotype is by far the most common mechanism of erythromycin resistance among Streptococcus pyogenes isolates in Spain. A geographic analysis of the relationship between within-country differences in the prevalence of M-type resistance to erythromycin in S. pyogenes and the level of consumption of 14- and 15-membered macrolides within different provinces was carried out. From 1998 to 1999, a nationwide multicenter surveillance study yielded 2,039 consecutive pharyngeal isolates of S. pyogenes. Data on antibiotic consumption for the same period were gathered from IMS Health, and the corresponding daily defined doses per 1,000 inhabitants per day were calculated according to the Anatomic Therapeutic Classification index. Macrolide use was subdivided into dosages given three times a day (TID), twice a day (BID), or once a day (OD). Spearman nonparametric correlation coefficients (R) were calculated, and variables proving to be significantly associated (P < 0.1) were introduced into a linear regression model. The total consumption of macrolides presented a significant correlation with the prevalence of resistance (R = 0.527; P = 0.032). Neither TID nor BID macrolide consumption showed significant correlations. Only OD consumption had a significance below 0.1. These data are consistent with the hypothesis that only the total consumption of macrolides influences the local rates of M-type erythromycin resistance in S. pyogenes, and subgroups of macrolides seem to have an additive rather than a selective effect by contributing to increasing the final amount of macrolides used. Local variations in total consumption were associated only with BID consumption (R = 0.849; P = 0.004). The simple linear regression with total macrolide consumption showed a considerable determination coefficient (R(2) = 0.678; P = 0.006). The model explains up to 68% of the measured variation and is clearly better as a predictor of the prevalence of resistance than the mere mean is. By solving the regression equation, the resultant value of 2.2 defined doses per 1,000 inhabitants per day fits with the existence of a critical threshold of selective pressure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149359      PMCID: PMC120652          DOI: 10.1128/JCM.40.8.2959-2963.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone.

Authors:  M C Enright; B G Spratt; A Kalia; J H Cross; D E Bessen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 2.  Minimizing potential resistance: a population dynamics view.

Authors:  B R Levin
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

3.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

4.  Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.

Authors:  Ralf René Reinert; Adnan Al-Lahham; Maria Lemperle; Christoph Tenholte; Claudia Briefs; Stefan Haupts; Hans Hubert Gerards; Rudolf Lütticken
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

5.  Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci.

Authors:  D E Bessen; M W Izzo; T R Fiorentino; R M Caringal; S K Hollingshead; B Beall
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

Review 6.  Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents.

Authors:  G Peter
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

7.  Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  R Gómez-Lus; J J Granizo; L Aguilar; E Bouza; A Gutierrez; J García-de-Lomas
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.

Authors:  G Cornaglia; M Ligozzi; A Mazzariol; L Masala; G Lo Cascio; G Orefici; R Fontana
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

9.  Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.

Authors:  S Maruyama; H Yoshioka; K Fujita; M Takimoto; Y Satake
Journal:  Am J Dis Child       Date:  1979-11

10.  Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan.

Authors:  P R Hsueh; H M Chen; A H Huang; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

View more
  14 in total

1.  Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors:  S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  Evolution and global dissemination of macrolide-resistant group A streptococci.

Authors:  D Ashley Robinson; Joyce A Sutcliffe; Wezenet Tewodros; Anand Manoharan; Debra E Bessen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

4.  Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas.

Authors:  Susana Chavez-Bueno; Bülent Bozdogan; Kathy Katz; Karen L Bowlware; Nancy Cushion; Dominick Cavuoti; Naveed Ahmad; George H McCracken; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.

Authors:  Meredith E Hasenbein; John E Warner; Kathleen G Lambert; Sarah E Cole; Andrew B Onderdonk; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

6.  Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  Pauliina Kärpänoja; Solja T Nyberg; Miika Bergman; Tinna Voipio; Pirkko Paakkari; Pentti Huovinen; Hannu Sarkkinen
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

7.  Antibiotic resistant beta-hemolytic streptococci.

Authors:  Charmaine A C Lloyd; Swarna E Jacob; Thangam Menon
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 1.967

8.  Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.

Authors:  F Montagnani; L Stolzuoli; L Croci; C Rizzuti; F Arena; A Zanchi; C Cellesi
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

9.  Systemic antibiotic use among children and adolescents in Germany: a population-based study.

Authors:  Jakob Holstiege; Edeltraut Garbe
Journal:  Eur J Pediatr       Date:  2013-02-10       Impact factor: 3.183

Review 10.  Population biology of the human restricted pathogen, Streptococcus pyogenes.

Authors:  Debra E Bessen
Journal:  Infect Genet Evol       Date:  2009-03-21       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.